News for Fresenius Medical Care AG & Co. KGaA (FMS)

Fresenius Medical Care (NYSE: FMS) is one of the largest integrated providers of products and services for individuals undergoing dialysis following chronic kidney failure.

As per Fortune Business Insights’ report, the Continuous Renal Replacement Therapy Market share sector attained a worth of USD 1.04 Billion in 2023. Forecasts indicate a promising path, foreseeing a…

As per Fortune Business Insights’ report, the continuous renal replacement therapy Industry share sector attained a worth of USD 1.04 Billion in 2023. Forecasts indicate a promising path, foreseeing…

Urology device manufacturers should focus more on South Asia & Pacific countries, especially India, due to the large diabetic patient pool, says Fact.MR....

Innovations in urinary catheter designs such as hydrophilic coatings and antimicrobial agents enhancing patient comfort and driving product sales, says...

As per Fortune Business Insights’ report, the continuous renal replacement therapy Market share sector attained a worth of USD 1.04 Billion in 2023. Forecasts indicate a promising path ahead…

David Adlington from JP Morgan retains his negative opinion on the stock with a Sell rating. The target price is still set at EUR 42.30.

Fresenius Medical Care AG Hof Annual General Meeting on 16 May 2024 - Information pursuant to Table 8 of the Annex to the Implementing...

The medical oxygen cylinders market is anticipated to grow in the future owing to rising cases of respiratory ailments like COVID-19, pneumonia, asthma,...

Christian Ehmann from Warburg Research retains his negative opinion on the stock with a Sell rating. The target price remains unchanged at EUR 26.

GuruFocus is pleased to announce an upcoming interview with Robert Wyckoff and Jay Hill, two of the members of Tweedy Browne's investment and management committ

Insight into Tweedy Browne (Trades, Portfolio)'s Q3 2023 Investment Moves and Top Holdings Renowned for its adherence to the value investing principles of Benj

Gainers

Growth in a number of dialysis centers, increase in critical care admissions, presence of a large geriatric population, and government initiatives to...

FMI Funds recently published its Q2 2023 shareholder letter. Click here for more on FMI Funds' fund performance and strategic insights.

Markets move in cycles and today investors are throwing money hand-over-fist at the technology sector. Click here to read the full fund letter.

Prophecy Market Insights' latest research report on the Hemodialysis Concentrates Market provides a comprehensive analysis of the current market scenario,...

The North America renal insufficiency treatment market is one of the largest in the world, with the United States and Canada being the major contributors....

/PRNewswire/ -- The